(Yang Lin and Song Liu Jingyi, a reporter from the Peoples Daily Health Client) In January 2024, the National Medical Insurance Bureau issued a notice that until the end of March 2024, the general name, brand, dosage, specifications, specifications, specifications, specifications,The same pharmaceuticals ("Four Same Drugs") in inter -provincial unfair high prices and discrimination high prices, promote the price behavior of pharmaceutical enterprises more fair and honest, and promote the price of inter -provincial price more transparent and balanced.
Peoples Daily Health Client noticed that in many places, the price of drug prices is rectified to punch and adjust the price of related enterprises.In terms of purchasing price in Liaoning, the current hanging price of Ginkgo Da Mono in Guizhou is 51.01 yuan, and the price after the adjustment is 51 yuan, which is only one penny.
"This notification has increased its efforts to rectify the price rectification of Simi Pharmaceutical". Although the price reduction is small, it is significant, but it is significant.Money must also be reduced, reflecting the determination of the national medical insurance department to rectify drug prices. "On February 23, Huang Xiuxiang, the former secretary -general of the Hunan Pharmaceutical Circus Association, told the Peoples Daily Health Client reporter.
On February 20, the Shanxi Provincial Pharmaceutical Real Estate Bidding Purchasing Center issued the "Notice on the Price of Related Products for Some Enterprises" to adjust the pricePrice adjustment results.
On the same day, the Liaoning Provincial Public Resources Trading Center issued a notice to carry out the comparison work of some of the provinces hanging products, and publicized the procurement price adjustment results of drug hanging networks.The institution began to implement the new hanging price on the same day.In addition, Beijing, Zhejiang, Guangxi and other provinces also issued documents that pharmaceutical companies must rectify the price of the product, and "must not withdraw the network to avoid inspections."
Reporters from the Peoples Daily Health Client combed and found that in the drug price adjustment directory in Liaoning and Shanxi Province, 20 drugs are overwhelmed.After the price adjustment, the prices of drugs of the two provinces are exactly the same. For example, 0.25 grams of Yunnan Baiyao Capsules produced by Yunnan Baiyao Group were adjusted to 33.38 yuan.
It is understood that the National Medical Insurance Bureaus "Report on the Rectification of the Price of Pharmaceutical Consumption" mentioned in the centralized bidding and procurement center of Shanxi Provincial Pharmaceuticals and Procurement Procurement Center has not yet been released. According to Liaoning and ShanxiThe notice issued by other places, this document is mainly to notify some drugs and enterprises that have not reduced prices in time.
"The" Four Same Medicines "of this centralized rectification is mostly auxiliary medications.Implementation, most drug prices have become transparent, but comprehensive information sharing has not been achieved between provincial recruitment platforms. "Huang Xiuxiang said that the National Medical Insurance Bureau has achieved the information system of provinces, and the provinces have realized the interconnection of information interconnection in various provinces.Monitoring and comparison of drug prices on the official website of various provinces have strongly guaranteed the open and transparent of drug listing prices.
In order to ensure the fair and reasonable price of the price of the "four same medicines" between different regions, how to build and improve the long -term management system?
Fan Shigan, an associate professor of the Institute of Economics and Law, China University of Political Science and Law, told a reporter from the Health Client of the Peoples Daily that first of all, the national unified national price linkage rules need to be built.At present, there are differences in the policy details of the price linkage of the "four same medicines" in various provinces. These details may lead to the unfair and reasonable prices of "four same medicines" in individual regions.Pharmaceutical companies have no loopholes to drill.
Second, establish a national unified national medical security information platform drug and medical consumables recruitment management subsystem, solve the phenomenon of "information islands", and effectively curb enterprises to use information poorly in some provinces.Reasonable or discriminatory high prices.
Establish a perfect daily price monitoring system.For medical consumables that are included in the procurement tracking monitoring list or key medical consumable monitoring list, the national unified national testing requirements are stipulated, such as the increase or price increase standard, and the clear monitoring work system is stipulatedTreatment, etc.
